Australia markets closed

Race Oncology Limited (RAC.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
1.2900-0.0150 (-1.15%)
At close: 04:10PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 213.98M
Enterprise value 200.26M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)10.47
Enterprise value/revenue N/A
Enterprise value/EBITDA -11.38

Trading information

Stock price history

Beta (5Y monthly) 1.50
52-week change 3-32.11%
S&P500 52-week change 322.64%
52-week high 31.9250
52-week low 30.6400
50-day moving average 31.2150
200-day moving average 30.9884

Share statistics

Avg vol (3-month) 3146.42k
Avg vol (10-day) 3104.35k
Shares outstanding 5165.87M
Implied shares outstanding 6165.87M
Float 8110.76M
% held by insiders 127.22%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -192.15%
Operating margin (ttm)-151.66%

Management effectiveness

Return on assets (ttm)-28.46%
Return on equity (ttm)-43.67%

Income statement

Revenue (ttm)5.82M
Revenue per share (ttm)0.04
Quarterly revenue growth (yoy)202.80%
Gross profit (ttm)N/A
EBITDA -11.71M
Net income avi to common (ttm)-11.17M
Diluted EPS (ttm)-0.0700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)13.72M
Total cash per share (mrq)0.08
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)28.36
Book value per share (mrq)0.12

Cash flow statement

Operating cash flow (ttm)-12.94M
Levered free cash flow (ttm)-9.29M